3660 results for «275»

Filter By

3660 results

Complication management during STEMI intervention: Czech Republic - Greece and Iraq present their cases

21 May 2026 – From EuroPCR 2026

This session presents a critical analysis of procedural strategies in primary PCI for STEMI by exploring complex cases from the Czech Republic, Greece, and Iraq. It delves into mechanisms and management of major PCI complications and highlights the role of emerging novel technologies in primary PCI...

Case-based challenges and dilemmas in multivessel PCI

21 May 2026 – From EuroPCR 2026

This session addresses real-world challenges in multivessel PCI for stable and acute coronary syndromes, emphasizing decision-making, procedure planning, and complication management. It highlights the application of imaging, physiology, and contemporary tools such as DCB to optimize outcomes through illustrative cases from Bangladesh, Brunei Darussalam, and the...

SCAD, PCI specific strategies

21 May 2026 – From EuroPCR 2026

This session focuses on specific percutaneous coronary intervention strategies for spontaneous coronary artery dissection (SCAD) and related coronary anomalies. It covers clinical and therapeutic aspects of adult coronary aneurysms, woven coronary anomalies, innovative stent optimization techniques, microvascular dysfunction in takotsubo syndrome, and real-world management of SCAD...

Complication management after tricuspid valve interventions

21 May 2026 – From EuroPCR 2026

This session reviews complication management following tricuspid valve interventions, highlighting practical approaches to unexpected procedural events. Topics include management of TricValve pop-up complications, Evoque device challenges, acute leaflet thrombosis emergencies, and bailout strategies for single leaflet detachment in tricuspid transcatheter edge-to-edge repair (TEER).

First half of DK-Crush technique for bailout stenting of a true 0,0,1 bifurcation

09 Dec 2022

Stent implantation is largely debated in true 0,0,1 bifurcation lesion. This case shows bailout IVUS-guided stenting of a large diagonal branch after DEB-induced dissection, performed by employing the first half of the DK-Crush technique, thus avoiding stenting in the disease-free left anterior descending artery.

Giuseppe Andó

Author

Giuseppe Andó

Author

Marco Borgi

Author

Giulia Alagna
First half of DK-Crush technique for bailout stenting of a true 0,0,1 bifurcation

Observing an aorto-ostial lesion using TELESCOPE® in optical coherence tomography-guided percutaneous coronary intervention

17 Mar 2020

In OCT-guided PCI, observing an aorto-ostial lesion is impossible as it requires blood clearance, and the material of the guiding catheter used is not near-infrared transparent. Using a Telescope®-guiding extension catheter, the authors successfully acquired an OCT image throughout the soft polymer tip and the relatively wide...

Image in cardiology: Aorto-ostial lesion observation by OCT

SWISS-APERO: a randomized trial of the amulet versus watchman FLX devices for left atrial appendage closure

04 Nov 2021

The SWISS-APERO is a prospective, investigator-initiated, randomized, multi-center, and clinical trial designed to compare the Amulet and Watchman (2.5 and FLX) devices in a head-to-head fashion.

Francesco Costa

Author

Francesco Costa
SWISS-APERO: a randomized trial of the amulet versus watchman FLX devices for left atrial appendage closure

MedAlliance announces enrollment of first Patient in SELUTION SLR LOVE-DEB coronary study

07 Sep 2023

A lethal combination. simultaneous inferior and anterior STEMI with aborted sudden cardiac death and cardiogenic shock

11 Aug 2022

View this case of a 60-year-old male with hypertension as a modifiable cardiovascular risk factor. A history of thoracic surgery for a gunshot wound 40 years ago and no cardiovascular history.

Authors :

Juan Guzmán Olea, Miguel Ángel Gómez Pluma, Gabriel Guzmán Olea, Juan Francisco Rodríguez Alvarado, Leticia Arizbeth Hernández Castro, Gonzalo Tolosa Dzul, Carlos Javier González Álvarez, Héctor Hugo Escutia Cuevas, Daniel Iván Pérez Vásquez
A lethal combination. Simultaneous inferior and anterior STEMI with aborted sudden cardiac death and cardiogenic shock

EuroPCR 2024: Late-breaking data demonstrate significant clinical advantage of Elixir Medical’s DynamX bioadaptor over standard-of-care drug-eluting stent at two years

14 May 2024

Elixir Medical’s DynamX Bioadaptor demonstrates significant improvement over contemporary drug-eluting stent in patients with acute coronary syndrome and complex lesion subsets after six months

28 Oct 2024

MERIL announces successful primary outcomes of next-gen Myval THV series in major RCT, presented at EuroPCR 2024 - Earns prestigious late Breaking trial status & The LANCET acceptance.

15 May 2024

TRANSFORM 1 Enrollment Completed: A Crucial RCT ready to redefine the DCB Angioplasty Mechanism

14 Sep 2022

The CLEAR SYNERGY (OASIS 9) Trial: A 2x2 factorial randomized controlled trial of colchicine versus placebo and spironolactone versus placebo in patients with myocardial infarction

18 Nov 2024

Mirvat Alasnag provides her take on the CLEAR SYNERGY trial presented by Sanjit S Jolly at AHA 2024 in Chicago.

Dr. Mirvat Alasnag

Author

Mirvat Alasnag
CLEAR SYNERGY

The Lancet Commission to reduce global burden of cardiovascular disease in women by 2030

29 Aug 2021

Vijay Kunadian summarizes the key points of the LBT session of the ESC congress 2021 held on Sunday, 29 August focusing on the Lancet Commission to reduce the global burden of heart disease in women by 2030.

Vijay Kunadian

Author

Vijay Kunadian
ESC Congress 2021 - Global burden of cardiovascular disease in women; 20/20 vision for 2030: report of The Lancet commission

TACSI: Dual or single antiplatelet therapy after CABG in patients with acute coronary syndrome

03 Sep 2025

Aaysha Cader provides her take on TACSI presented by Anders Jeppsson at ESC Congress 2025 in Madrid.

Author

Aaysha Cader
TACSI: Dual or single antiplatelet therapy after CABG in patients with acute coronary syndrome

EuroPCR 2023: Late-Breaking Clinical Data Demonstrate Elixir Medical’s DynamX Bioadaptor Restores Vessel Motion and Function with Better Effectiveness at 12 Months Compared to a Leading Drug-Eluting Stent (DES)

17 May 2023

Evidence base: A description of the key, so far published, studies in the space of drug coated balloons

23 Jan 2025

Authored by Hector Garcia-Garcia and Jorge Sanz-Sanchez, this article examines pivotal randomized clinical trials on drug-coated balloons in coronary artery disease. It highlights their role in managing in-stent restenosis, de novo small vessel lesions, and large vessel lesions while exploring future directions through ongoing trials.

Author

Hector Garcia-Garcia
Jorge Sanz Sanchez

Author

Jorge Sanz-Sanchez
Evidence base: A description of the key, so far published, studies in the space of drug coated balloons

Early intervention in patients with asymptomatic severe aortic stenosis and left ventricular myocardial fibrosis (EVOLVED)

30 Oct 2024

Ali Nazmi Calik provides his take on the EVOLVED trial presented by Marc Dweck at TCT 2024 in Washington.

Author

Ali Nazmi Calik
Early intervention in patients with asymptomatic severe aortic stenosis and left ventricular myocardial fibrosis (EVOLVED)

Transcatheter edge-to-edge repair in patients with severe mitral regurgitation and cardiogenic shock: Insights from the TVT Registry

17 Sep 2022

Mirvat Alasnag provides her take on the TEER Shock study which was presented at TCT 2022 by Mohamad A. Alkhouli.

Dr. Mirvat Alasnag

Author

Mirvat Alasnag
Transcatheter Edge-to-Edge Repair in Patients With Severe Mitral Regurgitation and Cardiogenic Shock: Insights From the TVT Registry
Didn’t find what you were looking for?